204 related articles for article (PubMed ID: 28253192)
1. The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction.
Dolinsky VW
Biol Chem; 2017 Aug; 398(9):955-974. PubMed ID: 28253192
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
He L; Liu F; Li J
Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin induced cardio toxicity through sirtuins mediated mitochondrial disruption.
Ahmad N; Ullah A; Chu P; Tian W; Tang Z; Sun Z
Chem Biol Interact; 2022 Sep; 365():110028. PubMed ID: 35921947
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway.
Danz ED; Skramsted J; Henry N; Bennett JA; Keller RS
Free Radic Biol Med; 2009 Jun; 46(12):1589-97. PubMed ID: 19303434
[TBL] [Abstract][Full Text] [Related]
5. Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice.
Pillai VB; Kanwal A; Fang YH; Sharp WW; Samant S; Arbiser J; Gupta MP
Oncotarget; 2017 May; 8(21):34082-34098. PubMed ID: 28423723
[TBL] [Abstract][Full Text] [Related]
6. Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins.
Dolinsky VW; Cole LK; Sparagna GC; Hatch GM
Biochim Biophys Acta; 2016 Oct; 1861(10):1544-54. PubMed ID: 26972373
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial sirtuins in the heart.
Bugger H; Witt CN; Bode C
Heart Fail Rev; 2016 Sep; 21(5):519-28. PubMed ID: 27295248
[TBL] [Abstract][Full Text] [Related]
8. Research progress on the role and mechanism of Sirtuin family in doxorubicin cardiotoxicity.
Zhang X; Huang C; Hou Y; Jiang S; Zhang Y; Wang S; Chen J; Lai J; Wu L; Duan H; He S; Liu X; Yu S; Cai Y
Phytomedicine; 2024 Jul; 129():155673. PubMed ID: 38677274
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy.
Carvalho FS; Burgeiro A; Garcia R; Moreno AJ; Carvalho RA; Oliveira PJ
Med Res Rev; 2014 Jan; 34(1):106-35. PubMed ID: 23494977
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-specific nano-emulsified therapy for myocardial protection against doxorubicin-induced cardiotoxicity.
Faulk A; Weissig V; Elbayoumi T
Methods Mol Biol; 2013; 991():99-112. PubMed ID: 23546663
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin.
Govender J; Loos B; Marais E; Engelbrecht AM
J Pineal Res; 2014 Nov; 57(4):367-80. PubMed ID: 25230823
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin Action on Mitochondria: Relevance to Osteosarcoma Therapy?
Armstrong J; Dass CR
Curr Drug Targets; 2018; 19(5):432-438. PubMed ID: 25882220
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity.
Cui L; Guo J; Zhang Q; Yin J; Li J; Zhou W; Zhang T; Yuan H; Zhao J; Zhang L; Carmichael PL; Peng S
Toxicol Lett; 2017 Jun; 275():28-38. PubMed ID: 28456571
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart.
Montaigne D; Marechal X; Baccouch R; Modine T; Preau S; Zannis K; Marchetti P; Lancel S; Neviere R
Toxicol Appl Pharmacol; 2010 May; 244(3):300-7. PubMed ID: 20096298
[TBL] [Abstract][Full Text] [Related]
15. New signal transduction paradigms in anthracycline-induced cardiotoxicity.
Ghigo A; Li M; Hirsch E
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775
[TBL] [Abstract][Full Text] [Related]
16. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.
Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Walker UA
Br J Pharmacol; 2007 Jul; 151(6):771-8. PubMed ID: 17519947
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.
Kluza J; Marchetti P; Gallego MA; Lancel S; Fournier C; Loyens A; Beauvillain JC; Bailly C
Oncogene; 2004 Sep; 23(42):7018-30. PubMed ID: 15273722
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the aging human heart: decreased sirtuins, pro-inflammatory shift and reduced anti-oxidative defense.
Barcena de Arellano ML; Pozdniakova S; Kühl AA; Baczko I; Ladilov Y; Regitz-Zagrosek V
Aging (Albany NY); 2019 Apr; 11(7):1918-1933. PubMed ID: 30964749
[TBL] [Abstract][Full Text] [Related]
19. Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.
Tokarska-Schlattner M; Wallimann T; Schlattner U
C R Biol; 2006 Sep; 329(9):657-68. PubMed ID: 16945832
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.
Wallace KB; Sardão VA; Oliveira PJ
Circ Res; 2020 Mar; 126(7):926-941. PubMed ID: 32213135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
